Growth Metrics

Edwards Lifesciences (EW) Consolidated Net Income (2016 - 2025)

Edwards Lifesciences has reported Consolidated Net Income over the past 17 years, most recently at $27.0 million for Q4 2025.

  • Quarterly results put Consolidated Net Income at $27.0 million for Q4 2025, down 31.3% from a year ago — trailing twelve months through Dec 2025 was $13.4 million (down 99.52% YoY), and the annual figure for FY2025 was $13.4 million, down 99.52%.
  • Consolidated Net Income for Q4 2025 was $27.0 million at Edwards Lifesciences, up from -$2.0 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for EW hit a ceiling of $2.7 billion in Q3 2024 and a floor of -$7.2 million in Q1 2025.
  • Median Consolidated Net Income over the past 5 years was $51.4 million (2023), compared with a mean of $289.7 million.
  • Biggest five-year swings in Consolidated Net Income: soared 5447.75% in 2024 and later tumbled 540.0% in 2025.
  • Edwards Lifesciences' Consolidated Net Income stood at $335.3 million in 2021, then tumbled by 40.2% to $200.5 million in 2022, then crashed by 81.75% to $36.6 million in 2023, then grew by 7.38% to $39.3 million in 2024, then plummeted by 31.3% to $27.0 million in 2025.
  • The last three reported values for Consolidated Net Income were $27.0 million (Q4 2025), -$2.0 million (Q3 2025), and -$4.4 million (Q2 2025) per Business Quant data.